調査レポートカテゴリー： Infiniti Research TechNavio, 世界, 医療/バイオ

Global Vasculitis Treatment Market 2017-2021

血管炎治療薬の世界市場

◆タイトル：Global Vasculitis Treatment Market 2017-2021
◆商品コード：IRTNTR13490
◆調査・発行会社：Technavio (Infiniti Research Ltd.)
◆発行日：2017年6月21日
◆ページ数：78
◆資料形式：PDF / 英語
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：医療・バイオ
◆販売価格オプション（消費税別）
Single User（1名利用）USD3,500 ⇒換算￥388,500見積依頼/購入/質問フォーム
Five User（～5名利用）USD4,000 ⇒換算￥444,000見積依頼/購入/質問フォーム
Enterprise License（全社内共有可）USD5,000 ⇒換算￥555,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。（但し、対応範囲は弊社で判断）
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

 【資料の概要】

当調査レポートでは、血管炎治療薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、血管炎治療薬の世界市場規模及び予測、薬剤種類別分析、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況、主要企業（ベンダー）分析などの情報をお届けいたします。

About Vasculitis TreatmentVasculitis is an autoimmune disorder that causes inflammation of the blood vessels. The body’s immune system attacks the blood vessels, which results in inflammation. When this inflammation occurs, the walls of the affected blood vessels get thicker and the passages through which the blood flows get narrower, which reduces the amount of blood and oxygen delivered to vital organs.

Technavio’s analysts forecast the global vasculitis treatment market to grow at a CAGR of 4.20 % during the period 2017-2021.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global vasculitis treatment market for 2017-2021. To calculate the market size, the report considers the sales from the drugs.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Vasculitis Treatment Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Bristol-Myers Squibb
• CELGENE
• F. Hoffmann-La Roche
• GlaxoSmithKline

[Other prominent vendors]
• Ablynx
• AB SCIENCES
• Acorda Therapeutics
• Alder Biopharmaceuticals
• Antares Pharma
• Astellas Pharma
• AstraZeneca
• Baxter
• Boehringer Ingelhein
• Can-Fite BioPharma
• Celltrion
• ChemoCentryx
• Coherus BioSciences
• Daiichi Sankyo
• Eisai
• Eli Lilly
• Gilead Sciences
• Hospira
• Idera
• Immunomedics
• ImmuPharma
• Incyte
• Invion
• KaloBios Pharmaceuticals
• Lexicon Pharmaceuticals
• Merck
• MedImmune
• Morphotek
• Novo Nordisk
• Novartis
• Opexa Therapeutics
• Principia
• Regeneron
• Sandoz
• Sanofi
• Santarus
• Takeda
• UCB
• Vaccinex
• Vertex Pharmaceuticals
• Vitae Pharmaceuticals

[Market driver]
• Promising pipeline
• For a full, detailed list, view our report

[Market challenge]
• Loss of patent exclusivity of branded therapies
• For a full, detailed list, view our report

[Market trend]
• Strategic alliances
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

Table of Contents
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
• Market outline

PART 05: Pipeline landscape

PART 06: Market landscape
• Market overview
• Five forces analysis

PART 07: Market segmentation by drug class
• Corticosteroids
• Immunosuppressants
• Biologics

PART 08: Geographical segmentation
• Vasculitis treatment market in Americas
• Vasculitis treatment market in EMEA
• Vasculitis treatment market in APAC

PART 09: Decision framework

PART 10: Drivers and challenges
• Market drivers
• Market challenges

PART 11: Market trends
• Increase in public awareness programs
• Strategic alliances
• Introduction of novel MOAs

PART 12: Vendor landscape
• Competitive scenario
• Key vendor analysis
• Bristol-Myers Squibb
• CELGENE
• F. Hoffmann-La Roche
• GlaxoSmithKline
• Other prominent vendors

PART 13: Appendix
• List of abbreviations

[List of Exhibits]
Exhibit 01: Forms of vasculitis based on sizes of blood vessels affected
Exhibit 02: Key clinical trials
Exhibit 03: Global vasculitis treatment market snapshot
Exhibit 04: Global vasculitis treatment market 2016-2021 ($ millions)
Exhibit 05: Opportunity analysis in global vasculitis treatment market
Exhibit 06: Five forces analysis
Exhibit 07: Market segmentation by drug class
Exhibit 08: Global vasculitis corticosteroid drugs market 2016-2021 ($ millions)
Exhibit 09: Global vasculitis immunosuppressant drugs market 2016-2021 ($ millions)
Exhibit 10: Global vasculitis biologics drugs market 2016-2021 ($ millions)
Exhibit 11: Segmentation of global vasculitis treatment market based on geography
Exhibit 12: Global vasculitis treatment market revenue by geography 2016-2021 ($ millions)
Exhibit 13: Market scenario in Americas
Exhibit 14: Vasculitis treatment market in the Americas 2016-2021 ($ millions)
Exhibit 15: Market scenario in EMEA
Exhibit 16: Vasculitis treatment market in EMEA 2016-2021 ($ millions)
Exhibit 17: Opportunity analysis for EMEA
Exhibit 18: Market Scenario of APAC
Exhibit 19: Vasculitis treatment market in APAC 2016-2021 ($ millions)
Exhibit 20: Opportunity analysis for APAC
Exhibit 21: Alternative therapies for vasculitis treatment
Exhibit 22: Adverse effects associated with vasculitis treatment
Exhibit 23: Alliances and agreements
Exhibit 24: List of few pipeline molecules with novel MOAs
Exhibit 25: Competitive structure analysis of global vasculitis treatment market 2016
Exhibit 26: Bristol-Myers Squibb: Key highlights
Exhibit 27: Bristol-Myers Squibb: Strength assessment
Exhibit 28: Bristol-Myers Squibb: Strategy assessment
Exhibit 29: Bristol-Myers Squibb: Opportunity assessment
Exhibit 30: CELGENE: Strength assessment
Exhibit 31: CELGENE: Strength assessment
Exhibit 32: CELGENE: Strategy assessment
Exhibit 33: CELGENE: Opportunity assessment
Exhibit 34: F. Hoffmann-La Roche: Key highlights
Exhibit 35: F. Hoffmann-La Roche: Strength assessment
Exhibit 36: F. Hoffmann-La Roche: Strategy assessment
Exhibit 37: F. Hoffmann-La Roche: Opportunity assessment
Exhibit 38: GlaxoSmithKline: Strength assessment
Exhibit 39: GlaxoSmithKline: Strategy assessment
Exhibit 40: GlaxoSmithKline: Opportunity assessment



【掲載企業】

Bristol-Myers Squibb, CELGENE, F. Hoffmann-La Roche, and GlaxoSmithKline.

Other Prominent Vendors in the market are: Ablynx, AB SCIENCES, Acorda Therapeutics, Alder Biopharmaceuticals, Antares Pharma, Astellas Pharma, AstraZeneca, Baxter, Boehringer Ingelhein, Can-Fite BioPharma, Celltrion, ChemoCentryx, Coherus BioSciences, Daiichi Sankyo, Eisai, Eli Lilly, Gilead Sciences, Hospira, Idera, Immunomedics, ImmuPharma, Incyte, Invion, KaloBios Pharmaceuticals, Lexicon Pharmaceuticals, Merck, MedImmune, Morphotek, Novo Nordisk, Novartis, Opexa Therapeutics, Principia, Regeneron, Sandoz, Sanofi, Santarus, Takeda, UCB, Vaccinex, Vertex Pharmaceuticals, and Vitae Pharmaceuticals.

【調査方法】

一次資料による調査（業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など）及び二次資料による調査（Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど）

★調査レポート[血管炎治療薬の世界市場] (Global Vasculitis Treatment Market 2017-2021 / IRTNTR13490)販売に関する免責事項
[血管炎治療薬の世界市場] (Global Vasculitis Treatment Market 2017-2021 / IRTNTR13490)についてEメールでお問い合わせ
◆関連調査資料◆
  • 移植片対宿主病(GVHD)治療薬の世界市場2017-2021
    IRTNTR14217 / Technavio / 2017年8月16日 / TechNavioが出版した当調査レポートでは、移植片対宿主病(GVHD)治療薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、疾患概要、移植片対宿主病(GVHD)治療薬の世界市場規模及び予測、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況、主要企業（ベンダー）分析などの情報をお届けいたします。Technavio社は移植片対宿主病(GVHD)治療薬の世界市場が2017-2021年期間中に年平均7.15%成長すると予測しています。当レポート上に記載されている主な企業は• Bristol-Myers Squibb• Novartis• Pfizer• F. Hoffmann-La Roche等です。...About Graft vs Host Disease (GVHD) Treatment Graft-versus-host disease (GVHD) is an immune-mediated disease, which results from a multifaceted interaction amongst donor and recipient's adaptive immunity. GVHD is an induced indication and emerges post organ or tissue transplant. The probability of developing GVHD is higher in allogeneic transplant, a transplant where donor's organ/cell are used for transplantation compared with autologous transplant, a transplant where individual's cells have been used for transplant. Technavio’s analysts forecast the global graft vs host disease (GVHD) treatment market to grow at a CAGR of 7.15% during the period 2017-2021. [Covered in this report] The report...
  • 膀胱癌治療の世界市場
    IRTNTR13172 / Technavio / 2017年5月31日 / 当調査レポートでは、膀胱癌治療の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、膀胱癌治療の世界市場規模及び予測、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況、主要企業（ベンダー）分析などの情報をお届けいたします。...About Bladder Cancer Therapeutics The bladder is an organ located in the lower abdominal region near the pelvic bones and acts as a reservoir of urine. A bladder cancer is characterized by the abnormal cell growth in the bladder, which impairs the proper functioning of urinary system. Majority of bladder cancer develops in the innermost layer called urothelium or transitional epithelium, composed of epithelium or transitional cells. Technavio’s analysts forecast the global bladder cancer therapeutics market to grow at a CAGR of 4.77% during the period 2017-2021. [Covered in this report] The report covers the present scenario and the growth...
  • カポジ肉腫治療の世界市場
    IRTNTR13093 / Technavio / 2017年5月3日 / 当調査レポートでは、カポジ肉腫治療の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、カポジ肉腫治療の世界市場規模及び予測、種類別分析、地域別分析/市場規模、市場の成長要因、市場の課題、製品パイプライン分析、市場動向、競争状況、主要企業（ベンダー）分析などの情報をお届けいたします。...About Kaposi SarcomaKaposi sarcoma is a multicentral tumor. The tumor is caused by Kaposi sarcoma-associated herpesvirus (KSHV) also known as human herpesvirus 8 (HHV8). It can occur as endemic, classic, epidemic, and iatrogenic forms. Epidemic or acquired immune deficiency syndrome (AIDS)-associated form of treatment is one of the most prevalent types followed in the treatment of Kaposi sarcoma globally. The diagnosis is done by biopsy, and major treatment types include chemotherapy, HAART, and immunotherapy. HAART is the most common type of treatment due to a high prevalence rate of AIDS-associated Kaposi sarcoma. Technavio’s analysts forecast the global Kaposi sarcoma market...
  • 双極性障害治療薬の世界市場2017-2021
    IRTNTR12440 / Technavio / 2017年4月12日 / 当調査レポートでは、双極性障害治療薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、疾患概要、双極性障害治療薬の世界市場規模及び予測、薬剤種類別分析、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況、主要企業（ベンダー）分析などの情報をお届けいたします。...About Bipolar Disorder TherapeuticBipolar disorder, also called manic-depressive disorder, is a mental disorder that causes unusual mood swings in patients. The disease causes periods of depression and mania in patients. Technavio’s analysts forecast the global bipolar disorder therapeutic market to grow at a CAGR of 2.22% during the period 2017-2021. [Covered in this report] The report covers the present scenario and the growth prospects of the global bipolar disorder therapeutic market for 2017-2021. To calculate the market size, the report considers the sales of drugs in the bipolar disorder therapeutic market. The market is divided into the following segments based...
  • 抗ウイルス薬の世界市場2017-2021
    IRTNTR11394 / Technavio / 2017年3月8日 / 当調査レポートでは、抗ウイルス薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、疾患概要、抗ウイルス薬の世界市場規模及び予測、地域別分析/市場規模、市場の成長要因、市場の課題、製品パイプライン分析、市場動向、主要企業（ベンダー）分析などの情報をお届けいたします。...About Antiviral DrugsAntiviral drugs are agents used to cure a viral infection by inhibiting the growth of viral pathogens. There are two types of antiviral agents which includes narrow-spectrum antiviral agents and broad-spectrum antiviral agents. Technavio’s analysts forecast the global antiviral drugs market to grow at a CAGR of 9.48% during the period 2017-2021. [Covered in this report] The report covers the present scenario and the growth prospects of the global antiviral drugs market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of antiviral drugs. The market is divided into the following...
  • 抗凝血剤の世界市場2017-2021
    IRTNTR12016 / Technavio / 2017年2月16日 / 当調査レポートでは、抗凝血剤の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、疾患概要、抗凝血剤の世界市場規模及び予測、用途別分析、薬剤種類別分析、市場シェア、地域別分析/市場規模、市場の成長要因、市場の課題、製品パイプライン分析、市場動向、競争状況、主要企業（ベンダー）分析などの情報をお届けいたします。...ABSTRACTAbout Anticoagulant Market Anticoagulant prevent clot formations or the enlargement of existing clots in the arteries or veins. Heparins, including unfractionated heparin (UFH) and low molecular weight heparin (LMWH); vitamin K antagonists; DTIs; and factor Xa inhibitors are among the anticoagulant that are available in the market. They are used for indications such as heart attack, stroke, deep venous thrombosis (DVT), pulmonary embolism (PE), surgery, angina, dialysis, atrial fibrillation (AF), thrombocytopenia, and myocardial infarction. Bayer HealthCare, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Johnson & Johnson, and Sanofi are some of the top vendors in the market. Technavio’s analysts forecast the...
  • がん治療用モノクローナル抗体（MAb）の世界市場2017-2021
    IRTNTR11278 / Technavio / 2016年12月27日 / 当調査レポートでは、がん治療用モノクローナル抗体（MAb）の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、がん治療用モノクローナル抗体（MAb）の世界市場規模及び予測、種類別分析、市場シェア、地域別分析/市場規模、購買基準、市場の成長要因、市場の課題、市場動向、競争状況、主要企業（ベンダー）分析などの情報をお届けいたします。...About Cancer Monoclonal AntibodiesThe mAbs, which are produced by genetic engineering, target antigens in cells, tissues, and organs. They are used in clinical applications to treat diseases with excellent efficacy and minimal side effects. Their MOA, absence of generic pathway, and therapeutic applications distinguish them from other targeted therapeutics. Technavio’s analysts forecast the global cancer monoclonal antibodies market to grow at a CAGR of 10.86% during the period 2017-2021. [Covered in this report] The report covers the present scenario and the growth prospects of the global cancer monoclonal antibodies market for 2017-2021. To calculate the market size, the report considers...
  • 世界の関節リウマチ（RA）治療薬市場（2014-2018）
    IRTNTR3808 / Technavio / 2014年7月14日 / ...About Rheumatoid Arthritis RA is a chronic disease that leads to inflammation and pain in the human body's joints such as wrists, fingers, knees, feet, and ankles. In addition, it causes inflammation of the tissues that surround the joints and in other organs. The symptoms of RA begin slowly, usually just mild pain around the joints coupled with stiffness and fatigue, and in the later stages it causes inflammation of the joints. It can occur at any age, even in children, which is called juvenile arthritis. The disease is three times more common in women than in men. Genetic and...
  • 世界の非ホジキンリンパ腫治療市場（2014-2018）
    IRTNTR3709 / Technavio / 2014年6月30日 / ...About Non-Hodgkin Lymphoma (NHL) and its Diagnostic Procedures Non-Hodgkin lymphoma (NHL) is a condition of the human body leading to the production of abnormal lymphocytes. In normal circumstances, the lymphocytes grow and die. However, in NHL they do not die; instead they grow and further divide. NHL can begin either in the T-cells or B-cells, though mostly it begins in the B-cells. The location of NHL is generally in the lymph nodes, but it can also spread to the body’s lymphatic system. It has many symptoms, of which swelling in the lymph nodes, abdominal pain, chest pain, cough, fever, fatigue,...
  • 世界の白血病治療市場動向（2012-2016）
    IRTNTR1978 / Technavio / 2013年3月11日 / ...TechNavio’s analysts forecast the Global Leukemia Therapeutics market to grow at a CAGR of 10 percent over the period 2012-2016. One of the key factors contributing to this market growth is the significant increase in the number of cancer patients worldwide. The Global Leukemia Therapeutics market has also been witnessing an increase in the number of mergers and acquisitions. However, the delay in cancer diagnosis could pose a challenge to the growth of this market. TechNavio’s report, Global Leukemia Therapeutics Market 2012-2016, has been prepared based on an in-depth market analysis of the market with inputs from industry experts. The...

    • ◆H&Iグローバルリサーチ株式会社のお客様（例）◆